Publication

HOME > Publication > Publication 2012
Publication 2012
  1. Kohno S, Izumikawa K, Yoshida M, Takesue Y, Oka S, Kamei K, Miyazaki Y, Yoshinari T, Kartsonis NA, Niki Y: A double-blind comparative study of the safety and efficacy of caspofungin versus micafungin in the treatment of candidiasis and aspergillosis. Eur J Clin Microbiol Infect Dis Oct 3, 2012
  2. Yamamoto Y, Izumikawa K, Morinaga Y, Nakamura S, Kurihara S, Imamura Y, Miyazaki T, Tsukamoto M, Kakeya H, Yanagihara K, Yasuoka A, Kohno S. Prospective randomized comparison study of piperacillin/tazobactam and meropenem for healthcare-associated pneumonia in Japan. J Infect Chemother. 2013 Jan 24
  3. Yamamoto Y, Izumikawa K, Hosogaya N, Morinaga Y, Nakamura S, Imamura Y, Miyazaki T, Sakamoto N, Ishimatsu Y, Kakeya H, Yanagihara K, Yasuoka A, Kohno S. A case of refractory chronic respiratory tract infection due to Pseudomonas aeruginosa successfully controlled by combination of clarithromycin and azithromycin. Intern Med. 51: 1383-6, 2012.
  4. Yamamoto Y, Izumikawa K, Hashiguchi K, Fukuda Y, Kobayashi T, Kondo A, Inoue Y, Morinaga Y, Nakamura S, Imamura Y, Miyazaki T, Kakeya H, Yanagihara K, Kohno S. The efficacy and safety of high-dose arbekacin sulfate therapy (once-daily treatment) in patients with MRSA infection. J Infect Chemother. 18: 241-6, 2012.
  5. Izumikawa K, Yamamoto Y, Mihara T, Takazono T, Morinaga Y, Kurihara S, Nakamura S, Imamura Y, Miyazaki T, Nishino T, Tsukamoto M, Kakeya H, Yanagihara K, Mine M, Yasuoka A, Tashiro T, Kohno S. Bronchoalveolar lavage galactomannan for the diagnosis of chronic pulmonary aspergillosis. Med Mycol. 50: 811-7, 2012.
  6. Izumikawa K, Yamamoto Y, Yanagihara K, Kiya T, Matsuda J, Morinaga Y, Kurihara S, Nakamura S, Imamura Y, Miyazaki T, Nishino T, Tsukamoto M, Kakeya H, Yasuoka A, Tashiro T, Kamihira S, Kohno S. Active surveillance of methicillin-resistant Staphylococcus aureus with the BD GeneOhm MRSA™ assay in a respiratory ward in Nagasaki, Japan. Jpn J Infect Dis. 65: 33-6, 2012.
  7. Takazono T, Izumikawa K, Yoshioka S, Matsuo N, Yamakawa M, Suyama N, Kohno S. Possible pulmonary cryptococcosis in a patient with Crohn's disease during anti-tumor necrosis factor-alpha treatment: a case report and literature review. Jpn J Infect Dis. 65: 461-4, 2012.
  8. Mihara T, Izumikawa K, Kakeya H, Ngamskulrungroj P, Umeyama T, Takazono T, Tashiro M, Nakamura S, Imamura Y, Miyazaki T, Ohno H, Yamamoto Y, Yanagihara K, Miyzaki Y, Kohno S. Multilocus sequence typing of Cryptococcus neoformans in non-HIV associated cryptococcosis in Nagasaki, Japan. Med Mycol. 2012 Aug 17.
  9. Nagaoka K, Izumikawa K, Yamamoto Y, Yanagihara K, Ohkusu K, Kohno S. A case of multiple lung abscesses caused by Actinomyces graevenitzii mimicking acute pulmonary coccidioidomycosis. J Clin Microbiol. 50: 3125-8, 2012.
  10. Tashiro M, Izumikawa K, Hirano K, Ide S, Mihara T, Hosogaya N, Takazono T, Morinaga Y, Nakamura S, Kurihara S, Imamura Y, Miyazaki T, Nishino T, Tsukamoto M, Kakeya H, Yamamoto Y, Yanagihara K, Yasuoka A, Tashiro T, Kohno S. Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus. Antimicrob Agents Chemother. 56: 4870-5, 2012
  11. Tashiro M, Izumikawa K, Minematsu A, Hirano K, Iwanaga N, Ide S, Mihara T, Hosogaya N, Takazono T, Morinaga Y, Nakamura S, Kurihara S, Imamura Y, Miyazaki T, Nishino T, Tsukamoto M, Kakeya H, Yamamoto Y, Yanagihara K, Yasuoka A, Tashiro T, Kohno S. Antifungal susceptibilities of Aspergillus fumigatus clinical isolates in Nagasaki, Japan. Antimicrob Agents Chemother. 56: 584-587, 2012.
  12. Fukuda M, Nakamura Y, Kinoshita A, Soejima Y, Yamaguchi H, Ikeda T, Izumikawa K, Takatani H, Fukuda M, Soda H, Hayashi N, Tsukamoto K, Oka M, Kohno S: Phase II study of irinotecan and cisplatin with concurrent split-course radiotherapy in limited-disease small cell lung cancer. Cancer Chemother Pharmacol Aug 22, 2012
  13. Kaku N, Yanagihara K, Morinaga Y, Izumikawa K, Nagashima S, Kakeya H, Yamamoto Y, Fukuda M, Takatani H, Fukuda M, Hashiguchi K, Kohno S: The definition of healthcare-associated pneumonia (HCAP) is insufficient for the medical environment in Japan: a comparison of HCAP and nursing and healthcare-associated pneumonia (NHCAP). J Infect Chemother  Aug 1, 2012
  14. Morinaga Y, Yanagihara K, Araki N, Migiyama Y, Nagaoka K, Harada Y, Yamada K, Hasegawa H, Nishino T, Izumikawa K, Kakeya H, Yamamoto Y, Kohno S, Kamihira S: Live Legionella pneumophila induces MUC5AC production by airway epithelial cells independently of intracellular invasion. Can J Microbiol 58: 151-7, 2012
  15. Yamada K, Yamamoto Y, Yanagihara K, Araki N, Harada Y, Morinaga Y, Izumikawa K, Kakeya H, Hasegawa H, Kohno S, Kamihira S: In vivo efficacy and pharmacokinetics of biapenem in a murine model of ventilator-associated pneumonia with Pseudomonas aeruginosa. J Infect Chemother 18: 472-8, 2012
  16. Yamada K, Yanagihara K, Araki N, Harada Y, Morinaga Y, Akamatsu N, Matsuda J, Izumikawa K, Kakeya H, Yamamoto Y, Hasegawa H, Kohno S, Kamihira S: Clinical characteristics of tertiary hospital patients from whom Acinetobacter calcoaceticus-Acinetobacter baumannii complex strains were isolated. Intern Med 51: 51-7, 2012
  17. Hosogaya N, Miyazaki T, Nagi M, Tanabe K, Minematsu A, Nagayoshi Y, Yamauchi S, Nakamura S, Imamura Y, Izumikawa K, Kakeya H, Yanagihara K, Miyazaki Y, Kugiyama K, Kohno S. The Heme-binding Protein Dap1 links Iron Homeostasis to Azole Resistance via the P450 Protein Erg11 in Candida glabrata. FEMS Yeast Res. 13(4): 411-421, 2013
  18. Miyazaki T, Nakayama H, Nagayoshi Y, Kakeya H, Kohno S. Dissection of Ire1 Functions Reveals Stress Response Mechanisms Uniquely Evolved in Candida glabrata. PLoS Pathog. 9(1): e1003160, 2013.
  19. Izumikawa K, Tashiro M, Kohno S. Management of chronic pulmonary aspergillosis. Ann N Y Acad Sci. 1272: 40-8, 2012.

(Presentations)

  1. 5th Advanced against Aspergillosis Izumikawa K: Management of chronic pulmonary aspergillosis
  2. 5th Advanced against Aspergillosis Ide S, Izumikawa K, Gyotoku H, Hirano K, Hosogaya N, Tashiro M, Mihara T, Morinaga Y, Nakamura S, Imamura Y, Miyazaki T, Ikeda H, Kakeya H, Yamamoto Y, Yanagihara K, Kanda T, Tashiro T, Kohno S: Bronchial Aspergillosis due to Aspergillus udagawae: a rare case report
  3. 5th Advanced against Aspergillosis Tashiro M, Izumikawa K, Hirano K, Ide S, Morinaga Y, Nakamura S, Imamura Y, Miyazaki T, Kakeya H, Yamamoto Y, Yanagihara K, Tashiro T, Kohno S: Antifungal susceptibility of Aspergillus fumigatus and relationship with azole exposure in Nagasaki, JAPAN
  4. 5th Advanced against Aspergillosis Hirano K, Izumikawa K, Tashiro M, Ide S, Morinaga Y, Kurihara S, Nakamura S, Imamura Y, Miyazaki T, Tsukamoto M, Kakeya H, Yamamoto Y, Yanagihara K, Tashiro T, Kohno S: A case of chronic pulmonary aspergillosis due to itraconazole low-susceptible Aspergillus fumigatus of which resistance acquired during long-term administration of itraconazole.
  5. 18th Congress of the International Society for Human and Animal Mycology Hirano K, Izumikawa K, Hamada Y, Takazono T, Ide S, Iwanaga N, Minematsu A, Tashiro M, Mihara T, Morinaga Y, Kurihara S, Nakamura S, Imamura Y, Miyazaki T, Tsukamoto M, Kakeya H, Yamamoto Y, Yanagihara K, Tashiro T, Kohno S: The correlation between serum trough levels and frequency of side effects of VRCZ at Nagasaki University Hospital, Nagasaki Japan
  6. 112th ASM 2012 Tanaka A, Nakamura S, Seki M, Iwanaga N,  Imamura Y, Miyazaki T, Izumikawa K, Kakeya H, Yamamoto Y, Yanagihara, Tashiro T, Kohno S: TLR4/MD2 Complex Agonistic Antibody Promotes Innate Host Resistance Against Secondary Pneumococcal Pneumonia Induced Co-infection With Influenza Virus
  7. 112th ASM Morinaga Y, Yanagihara K, Araki N, Harada Y, Migiyama Y, Nagaoka K, Yamada K, Akamatsu N, Matsuda J, Hasegawa H, Izumikawa K, Kakeya H, Yamamoto Y, Yasuoka A, Kohno S, Kamihira S: Clinical and Microbial Characteristics of Aeromonas Infections in a Japanese Hospital
  8. 112th ASM Harada Y,  Yanagihara K,  Morinaga Y,  Izumikawa K,  Kakeya H,  Yamamoto Y,  Kamihira S,  Kohno S: Efficacy of Daptomycin against methicillin-resistant Staphylococcus aureus （MRSA） in a murine model of haematogenous pulmonary infection
  9. 52nd ICAAC 2012 Tanaka A, Nakamura S, Iwanaga N, Kajihara T, Kitano M, Imamura Y, Miyazaki T, Seki M, Izumikawa K, Kakeya H, Yamamoto Y, Yanagihara K, Tashiro T, Kohno S: Efficacy of peramivir on the outcome of severe pneumococcal pneumonia induced by co-infection with influenza virus in comparison with oseltamivir in mice
  10. 52nd ICAAC Yamada K, Yanagihara K, Harada Y, Migiyama Y, Nagaoka K, Morinaga Y. Izumikawa K, Kakeya H, Yamamoto Y, Kohno S: Azithromycin Inhibit Muc5ac Induction By Multidrug-resistant Acinetobacter Baumannii In Airway Epithelial Cells
  11. 52nd ICAACMorinaga Y, Yanagihara K, Kaku N, Migiyama Y, Harada Y, Nagaoka K, Yamada K, Izumikawa K, Kakeya H, Yamamoto Y, Kohno S: Effects Of Recombinant Thrombomodulin In Combination With Antibiotics On A Murine Legionella Pneumonia Model
  12. 52nd ICAAC Morinaga Y, Yanagihara K, Kaku N, Migiyama Y, Harada Y, Nagaoka K, Yamada K, Izumikawa K, Kakeya H, Yamamoto Y, Kohno S: Effects Of Dagibatran On A Murine Model Of Staphylococcus aureus Hematogenous Pulmonary Infection
  13. 13th APCCMIYoshimura S, Tashiro M, Higashi Y S, Morinaga Y, Kurihara S, Nakamura S, Imamura Y, Miyazaki T, Tsukamoto M,　Izumikawa K,  Kakeya H, Yamamoto Y, Yanagihara K, Tashiro T, Kohno S: A case of chronic pulmonary aspergillosis due to itraconazole low-susceptible Aspergillus fumigatus of which resistance acquired during long-term administration of itraconazole
  14. 13th APCCMI Higashi Y,  Hirano K, Takazono T, Hamada Y, Yoshimura S, Morinaga Y, Kurihara S, Nakamura S, Imamura Y, Miyazaki T, Tsukamoto M,　Izumikawa K,  Kakeya H, Yamamoto Y, Yanagihara K, Tashiro T, Kohno S: The correlation between serum trough levels and frequency of side effects of voriconazole at Nagasaki University Hospital, Nagasaki Japan
  15. 17th APSR Shiraishi K, Sumiyoshi M, Nakamura S, Ide S, Yamamoto Y, Kohno Y, Fukuda Y, Ikeda H, Sasaki E, Yanagihara K, Higashiyama Y, Inoue Y, Fukushima K, Suyama N, Izumikawa K, Kohno S:  Epidemiology and Clinical Features of Pulmonary Nontuberculous Mycobacteriosis in Nagasaki, Japan
  16. 11th ASM Conference on Candida and CandidiasisHosogaya N, Miyazaki T, Kohno S: The heme-binding protein Dap1 is required for azole tolerance and virulence in Candida glabrata
  17. 18th Congress of the International Society for Human and Animal Mycology Minematsu A, Miyazaki T, Kohno S: The vacuolar H+-ATPase function is required for antifungal tolerance and virulence in Candida glabrata